Preliminary 4th quarter results. $12.0 million in net sales. Pathetic!

[anonymous]

No uptick or runway here. This is a multi-billion dollar selling space Esperion is operating in. This is totally weak and nothing but scraps. Amazing the board is still employed. How much longer!

 

[anonymous]

I've got the next strategy.

Build back runway and up tick better !!!

What do you think ?

 

[anonymous]

I've got the next strategy.

Build back runway and up tick better !!!

What do you think ?

Whatever you say Ann Arbor lackey!

 

[anonymous]

I don't think there are anymore lifelines left for Esperion. The results of the outcomes study would need to be biblical in nature and to keep the company afloat.

 

[anonymous]

And stock got into $3.00 range this am. Now stumbling around 3.88 to 4.04.Yoy would need something biblical in nature to ever get the stock back in the $70.00 range

 

[anonymous]

Well the market really has been tough on high flying biotechs of late, Definitely due for a big bounce, I think it’s safe to say the worst is behind us but short term volatility will continue. Long-term shareholder value is solid

 

[anonymous]

Well the market really has been tough on high flying biotechs of late, Definitely due for a big bounce, I think it’s safe to say the worst is behind us but short term volatility will continue. Long-term shareholder value is solid

Yes really high flying biotechnology. To bad Esperion isn't one of them. And it couldn't be a Esperion week waiting for the big bounce. The only big bounce Esperion will get is when they get bounced of the NYSE. Penny stock here we come. And if your a long-term shareholder ..."you've been played"

 

[anonymous]

Well the market really has been tough on high flying biotechs of late, Definitely due for a big bounce, I think it’s safe to say the worst is behind us but short term volatility will continue. Long-term shareholder value is solid

Wow.

You qualify to join the Biden Team to spin the abysmal inflation numbers !

 

[anonymous]

Wow.

You qualify to join the Biden Team to spin the abysmal inflation numbers !

For sure. Biden and Esperion go hand in hand. Fumbling,bumbling,stumbling. Confused ,reading a script,takes no questions and answers nothing. Above all incompetence rules with both. Esperion is a third rate investment scam at best. Biden is just senile.

 

[anonymous]

The stock is dropping again. $3.89 and falling. I guess the JP Morgan cup in hand investor meeting isn't going as planned and they got a whiff of the preliminary 4th quarter sales results.

 

[anonymous]

Investor confidence is mounting, seeing a positive turn towards the close. To be sure, the rotational shift away from high science bio tech has been brutal, but savvy investors look forward. The second half of the year will prove very interesting and likely quite profitable as the amateurs are washed out and the professionals take charge.

 

[anonymous]

Investor confidence is mounting, seeing a positive turn towards the close. To be sure, the rotational shift away from high science bio tech has been brutal, but savvy investors look forward. The second half of the year will prove very interesting and likely quite profitable as the amateurs are washed out and the professionals take charge.

This person has obviously attended the Jen Psaki Spin Class.

Nice paragraph saying nothing.

Perhaps you will be circling back ?

 

[anonymous]

So glad that the company is collapsing leave it at that.

 

[anonymous]

Investor confidence is mounting, seeing a positive turn towards the close. To be sure, the rotational shift away from high science bio tech has been brutal, but savvy investors look forward. The second half of the year will prove very interesting and likely quite profitable as the amateurs are washed out and the professionals take charge.

Yes the famous rotational shift scenario. Savvy investors will steer clear of this dumpster fire. What dummy would invest in Esperion when it was in the $70.00 range and now at 3.90. Sounds like a sound investment. And at no time has Esperion been considered a high flying biotechnology. We're talking about tricycle with training wheels with Esperion. Put a fork in this thing.

 

[anonymous]

Investor confidence is mounting, seeing a positive turn towards the close. To be sure, the rotational shift away from high science bio tech has been brutal, but savvy investors look forward. The second half of the year will prove very interesting and likely quite profitable as the amateurs are washed out and the professionals take charge.

Typical Esperion buffoonery. Never any clinical discussion and no solutions offered.

 

[anonymous]

The news that should hit this week will definitely put some jet fuel in the tank. Should be an interesting week as the squeeze begins, Shorts are getting tighter, you know what I mean squeaky balls?

 

[anonymous]

The news that should hit this week will definitely put some jet fuel in the tank. Should be an interesting week as the squeeze begins, Shorts are getting tighter, you know what I mean squeaky balls?

This above statement is another example of the caliber of individuals that were hired through the Scientific Process. Now it's jet fuel that's going to power Esperion. Not rotational shifts,runways,traction,upticks or other cosmic activities. Just watch what happens when the market opens this am. Esperion is going to drop a big duece this am.

 

[anonymous]

The news that should hit this week will definitely put some jet fuel in the tank. Should be an interesting week as the squeeze begins, Shorts are getting tighter, you know what I mean squeaky balls?

The Jen Psaki, Spin Graduate.

Is circling back.

You have learned well.

 

[anonymous]

The spin control douche has nothing to say about ESPR finishes at $3.72. Heads should be rolling in Ann Arbor. The entire salesforce needs to be clipped and replaced with a contract team.